Tag Archives: Glenmark Pharmaceuticals Ltd

GLENMARK PHARMA gets USFDA nod to market medicine to treat obesity

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Glenmark Pharmaceuticals Ltd said of having received USFDA (US Food and Drugs Administration) nod to market medicine to treat obesity and overweight related disorders. In a company press-release as submitted to the Indian Bourses, titled – “Glenmark

GLENMARK PHARMA gets USFDA nod to market SKIN-TREATMENT product

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered Glenmark Pharmaceuticals Ltd said of having got final approval from US FDA (Food & Drugs Administration) to sell dermatology (skin-treatment) product. The press-release as submitted by the company to the Indian Stock Exchanges – titled, “Glenmark Pharmaceuticals

GLENMARK gets USFDA nod to market medicine to treat BREAST-CANCER

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update filing sumitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharma company Glenmark Pharmaceuticals Ltd said of having got approval from US FDA (Food & Drugs Administration) to market injections to treat breast-cancer. The press-communication submitted by the company to the Indian Bourses titled –

Glenmark Pharma gets USFDA nod to market diabetes treatment drug

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT  – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Indian pharma major Glenmark Pharmaceuticals Ltd said of having got US FDA (Food & Drugs Administration) nod to market diabetes treatment drug. Press-release titled, “Glenmark receives approval for combination of Remogliflozin Etabonate and Metformin Hydrochloride for adults

Torrent Pharma inks diabetic drug marketing pact with Glenmark Pharma

AHMEDABAD | MUMBAI | RAJKOT –  In a press release submitted to the Indian Bourses by Glenmark Pharma it said that, Ahmedabad headquartered Torrent Pharmaceuticals and Glenmark Pharmaceuticals Ltd have inked agreement for co-marketing of diabetic treatment drug Remogliflozin Etabonate in India. The press release submitted to the Indian Exchanges on Thursday read that, Glenmark

Do NOT follow this link or you will be banned from the site!